The JV, Established in July 2021, Gets Renewal From Respective Partners Given Success in Increasing Adoption of Additively Manufactured Electronics […]
Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared […]